Immuno-oncology Diagnosis Market, Global Outlook and Forecast 2022-2028

March 2022 | 115 pages | ID: I551F7DEAA09EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Immuno-oncology Diagnosis in Global, including the following market information:

Global Immuno-oncology Diagnosis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Immuno-oncology Diagnosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Immuno-oncology Diagnosis include 10x Genomics, Abbott Laboratories, Abcam, Adaptive Biotechnologies, Aethlon Medical, Agena Bioscience, Angle plc, Apocell and ARUP Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immuno-oncology Diagnosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Immuno-oncology Diagnosis Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Immuno-oncology Diagnosis Market Segment Percentages, by Type, 2021 (%)

• PCR
• NGS
• Immunoassay

Global Immuno-oncology Diagnosis Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Immuno-oncology Diagnosis Market Segment Percentages, by Application, 2021 (%)

• Research
• Diagnostics

Global Immuno-oncology Diagnosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Immuno-oncology Diagnosis Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Immuno-oncology Diagnosis revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Immuno-oncology Diagnosis revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• 10x Genomics
• Abbott Laboratories
• Abcam
• Adaptive Biotechnologies
• Aethlon Medical
• Agena Bioscience
• Angle plc
• Apocell
• ARUP Laboratories
• Beckman Coulter
• Becton Dickinson
• Bioarray Genetics
• BioCartis
• Biocept
• Biodesix Inc
• BioFluidica
• BioGenex 40 bioM?rieux
• Bio-Rad
• Bio-Techne
• Bristol-Myers Squibb
• Cancer Genetics
• Caris Molecular Diagnostics
• CellMax Life
• Charles River Laboratories
• Chronix Biomedical
• Circulogene
• Clearbridge BioMedics
• Clinical Genomics
• Pfizer
• Promega
• Protagen Diagnostics
• Qiagen
• Quanterix
• Rarecells SAS
• Roche Diagnostics
• Siemens

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Immuno-oncology Diagnosis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Immuno-oncology Diagnosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL IMMUNO-ONCOLOGY DIAGNOSIS OVERALL MARKET SIZE

2.1 Global Immuno-oncology Diagnosis Market Size: 2021 VS 2028
2.2 Global Immuno-oncology Diagnosis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Immuno-oncology Diagnosis Players in Global Market
3.2 Top Global Immuno-oncology Diagnosis Companies Ranked by Revenue
3.3 Global Immuno-oncology Diagnosis Revenue by Companies
3.4 Top 3 and Top 5 Immuno-oncology Diagnosis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Immuno-oncology Diagnosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-oncology Diagnosis Players in Global Market
  3.6.1 List of Global Tier 1 Immuno-oncology Diagnosis Companies
  3.6.2 List of Global Tier 2 and Tier 3 Immuno-oncology Diagnosis Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Immuno-oncology Diagnosis Market Size Markets, 2021 & 2028
  4.1.2 PCR
  4.1.3 NGS
  4.1.4 Immunoassay
4.2 By Type - Global Immuno-oncology Diagnosis Revenue & Forecasts
  4.2.1 By Type - Global Immuno-oncology Diagnosis Revenue, 2017-2022
  4.2.2 By Type - Global Immuno-oncology Diagnosis Revenue, 2023-2028
  4.2.3 By Type - Global Immuno-oncology Diagnosis Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Immuno-oncology Diagnosis Market Size, 2021 & 2028
  5.1.2 Research
  5.1.3 Diagnostics
5.2 By Application - Global Immuno-oncology Diagnosis Revenue & Forecasts
  5.2.1 By Application - Global Immuno-oncology Diagnosis Revenue, 2017-2022
  5.2.2 By Application - Global Immuno-oncology Diagnosis Revenue, 2023-2028
  5.2.3 By Application - Global Immuno-oncology Diagnosis Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Immuno-oncology Diagnosis Market Size, 2021 & 2028
6.2 By Region - Global Immuno-oncology Diagnosis Revenue & Forecasts
  6.2.1 By Region - Global Immuno-oncology Diagnosis Revenue, 2017-2022
  6.2.2 By Region - Global Immuno-oncology Diagnosis Revenue, 2023-2028
  6.2.3 By Region - Global Immuno-oncology Diagnosis Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Immuno-oncology Diagnosis Revenue, 2017-2028
  6.3.2 US Immuno-oncology Diagnosis Market Size, 2017-2028
  6.3.3 Canada Immuno-oncology Diagnosis Market Size, 2017-2028
  6.3.4 Mexico Immuno-oncology Diagnosis Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Immuno-oncology Diagnosis Revenue, 2017-2028
  6.4.2 Germany Immuno-oncology Diagnosis Market Size, 2017-2028
  6.4.3 France Immuno-oncology Diagnosis Market Size, 2017-2028
  6.4.4 U.K. Immuno-oncology Diagnosis Market Size, 2017-2028
  6.4.5 Italy Immuno-oncology Diagnosis Market Size, 2017-2028
  6.4.6 Russia Immuno-oncology Diagnosis Market Size, 2017-2028
  6.4.7 Nordic Countries Immuno-oncology Diagnosis Market Size, 2017-2028
  6.4.8 Benelux Immuno-oncology Diagnosis Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Immuno-oncology Diagnosis Revenue, 2017-2028
  6.5.2 China Immuno-oncology Diagnosis Market Size, 2017-2028
  6.5.3 Japan Immuno-oncology Diagnosis Market Size, 2017-2028
  6.5.4 South Korea Immuno-oncology Diagnosis Market Size, 2017-2028
  6.5.5 Southeast Asia Immuno-oncology Diagnosis Market Size, 2017-2028
  6.5.6 India Immuno-oncology Diagnosis Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Immuno-oncology Diagnosis Revenue, 2017-2028
  6.6.2 Brazil Immuno-oncology Diagnosis Market Size, 2017-2028
  6.6.3 Argentina Immuno-oncology Diagnosis Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Immuno-oncology Diagnosis Revenue, 2017-2028
  6.7.2 Turkey Immuno-oncology Diagnosis Market Size, 2017-2028
  6.7.3 Israel Immuno-oncology Diagnosis Market Size, 2017-2028
  6.7.4 Saudi Arabia Immuno-oncology Diagnosis Market Size, 2017-2028
  6.7.5 UAE Immuno-oncology Diagnosis Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 10x Genomics
  7.1.1 10x Genomics Corporate Summary
  7.1.2 10x Genomics Business Overview
  7.1.3 10x Genomics Immuno-oncology Diagnosis Major Product Offerings
  7.1.4 10x Genomics Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.1.5 10x Genomics Key News
7.2 Abbott Laboratories
  7.2.1 Abbott Laboratories Corporate Summary
  7.2.2 Abbott Laboratories Business Overview
  7.2.3 Abbott Laboratories Immuno-oncology Diagnosis Major Product Offerings
  7.2.4 Abbott Laboratories Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.2.5 Abbott Laboratories Key News
7.3 Abcam
  7.3.1 Abcam Corporate Summary
  7.3.2 Abcam Business Overview
  7.3.3 Abcam Immuno-oncology Diagnosis Major Product Offerings
  7.3.4 Abcam Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.3.5 Abcam Key News
7.4 Adaptive Biotechnologies
  7.4.1 Adaptive Biotechnologies Corporate Summary
  7.4.2 Adaptive Biotechnologies Business Overview
  7.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Major Product Offerings
  7.4.4 Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.4.5 Adaptive Biotechnologies Key News
7.5 Aethlon Medical
  7.5.1 Aethlon Medical Corporate Summary
  7.5.2 Aethlon Medical Business Overview
  7.5.3 Aethlon Medical Immuno-oncology Diagnosis Major Product Offerings
  7.5.4 Aethlon Medical Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.5.5 Aethlon Medical Key News
7.6 Agena Bioscience
  7.6.1 Agena Bioscience Corporate Summary
  7.6.2 Agena Bioscience Business Overview
  7.6.3 Agena Bioscience Immuno-oncology Diagnosis Major Product Offerings
  7.6.4 Agena Bioscience Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.6.5 Agena Bioscience Key News
7.7 Angle plc
  7.7.1 Angle plc Corporate Summary
  7.7.2 Angle plc Business Overview
  7.7.3 Angle plc Immuno-oncology Diagnosis Major Product Offerings
  7.7.4 Angle plc Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.7.5 Angle plc Key News
7.8 Apocell
  7.8.1 Apocell Corporate Summary
  7.8.2 Apocell Business Overview
  7.8.3 Apocell Immuno-oncology Diagnosis Major Product Offerings
  7.8.4 Apocell Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.8.5 Apocell Key News
7.9 ARUP Laboratories
  7.9.1 ARUP Laboratories Corporate Summary
  7.9.2 ARUP Laboratories Business Overview
  7.9.3 ARUP Laboratories Immuno-oncology Diagnosis Major Product Offerings
  7.9.4 ARUP Laboratories Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.9.5 ARUP Laboratories Key News
7.10 Beckman Coulter
  7.10.1 Beckman Coulter Corporate Summary
  7.10.2 Beckman Coulter Business Overview
  7.10.3 Beckman Coulter Immuno-oncology Diagnosis Major Product Offerings
  7.10.4 Beckman Coulter Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.10.5 Beckman Coulter Key News
7.11 Becton Dickinson
  7.11.1 Becton Dickinson Corporate Summary
  7.11.2 Becton Dickinson Business Overview
  7.11.3 Becton Dickinson Immuno-oncology Diagnosis Major Product Offerings
  7.11.4 Becton Dickinson Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.11.5 Becton Dickinson Key News
7.12 Bioarray Genetics
  7.12.1 Bioarray Genetics Corporate Summary
  7.12.2 Bioarray Genetics Business Overview
  7.12.3 Bioarray Genetics Immuno-oncology Diagnosis Major Product Offerings
  7.12.4 Bioarray Genetics Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.12.5 Bioarray Genetics Key News
7.13 BioCartis
  7.13.1 BioCartis Corporate Summary
  7.13.2 BioCartis Business Overview
  7.13.3 BioCartis Immuno-oncology Diagnosis Major Product Offerings
  7.13.4 BioCartis Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.13.5 BioCartis Key News
7.14 Biocept
  7.14.1 Biocept Corporate Summary
  7.14.2 Biocept Business Overview
  7.14.3 Biocept Immuno-oncology Diagnosis Major Product Offerings
  7.14.4 Biocept Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.14.5 Biocept Key News
7.15 Biodesix Inc
  7.15.1 Biodesix Inc Corporate Summary
  7.15.2 Biodesix Inc Business Overview
  7.15.3 Biodesix Inc Immuno-oncology Diagnosis Major Product Offerings
  7.15.4 Biodesix Inc Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.15.5 Biodesix Inc Key News
7.16 BioFluidica
  7.16.1 BioFluidica Corporate Summary
  7.16.2 BioFluidica Business Overview
  7.16.3 BioFluidica Immuno-oncology Diagnosis Major Product Offerings
  7.16.4 BioFluidica Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.16.5 BioFluidica Key News
7.17 BioGenex 40 bioM?rieux
  7.17.1 BioGenex 40 bioM?rieux Corporate Summary
  7.17.2 BioGenex 40 bioM?rieux Business Overview
  7.17.3 BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Major Product Offerings
  7.17.4 BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.17.5 BioGenex 40 bioM?rieux Key News
7.18 Bio-Rad
  7.18.1 Bio-Rad Corporate Summary
  7.18.2 Bio-Rad Business Overview
  7.18.3 Bio-Rad Immuno-oncology Diagnosis Major Product Offerings
  7.18.4 Bio-Rad Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.18.5 Bio-Rad Key News
7.19 Bio-Techne
  7.19.1 Bio-Techne Corporate Summary
  7.19.2 Bio-Techne Business Overview
  7.19.3 Bio-Techne Immuno-oncology Diagnosis Major Product Offerings
  7.19.4 Bio-Techne Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.19.5 Bio-Techne Key News
7.20 Bristol-Myers Squibb
  7.20.1 Bristol-Myers Squibb Corporate Summary
  7.20.2 Bristol-Myers Squibb Business Overview
  7.20.3 Bristol-Myers Squibb Immuno-oncology Diagnosis Major Product Offerings
  7.20.4 Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.20.5 Bristol-Myers Squibb Key News
7.21 Cancer Genetics
  7.21.1 Cancer Genetics Corporate Summary
  7.21.2 Cancer Genetics Business Overview
  7.21.3 Cancer Genetics Immuno-oncology Diagnosis Major Product Offerings
  7.21.4 Cancer Genetics Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.21.5 Cancer Genetics Key News
7.22 Caris Molecular Diagnostics
  7.22.1 Caris Molecular Diagnostics Corporate Summary
  7.22.2 Caris Molecular Diagnostics Business Overview
  7.22.3 Caris Molecular Diagnostics Immuno-oncology Diagnosis Major Product Offerings
  7.22.4 Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.22.5 Caris Molecular Diagnostics Key News
7.23 CellMax Life
  7.23.1 CellMax Life Corporate Summary
  7.23.2 CellMax Life Business Overview
  7.23.3 CellMax Life Immuno-oncology Diagnosis Major Product Offerings
  7.23.4 CellMax Life Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.23.5 CellMax Life Key News
7.24 Charles River Laboratories
  7.24.1 Charles River Laboratories Corporate Summary
  7.24.2 Charles River Laboratories Business Overview
  7.24.3 Charles River Laboratories Immuno-oncology Diagnosis Major Product Offerings
  7.24.4 Charles River Laboratories Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.24.5 Charles River Laboratories Key News
7.25 Chronix Biomedical
  7.25.1 Chronix Biomedical Corporate Summary
  7.25.2 Chronix Biomedical Business Overview
  7.25.3 Chronix Biomedical Immuno-oncology Diagnosis Major Product Offerings
  7.25.4 Chronix Biomedical Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.25.5 Chronix Biomedical Key News
7.26 Circulogene
  7.26.1 Circulogene Corporate Summary
  7.26.2 Circulogene Business Overview
  7.26.3 Circulogene Immuno-oncology Diagnosis Major Product Offerings
  7.26.4 Circulogene Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.26.5 Circulogene Key News
7.27 Clearbridge BioMedics
  7.27.1 Clearbridge BioMedics Corporate Summary
  7.27.2 Clearbridge BioMedics Business Overview
  7.27.3 Clearbridge BioMedics Immuno-oncology Diagnosis Major Product Offerings
  7.27.4 Clearbridge BioMedics Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.27.5 Clearbridge BioMedics Key News
7.28 Clinical Genomics
  7.28.1 Clinical Genomics Corporate Summary
  7.28.2 Clinical Genomics Business Overview
  7.28.3 Clinical Genomics Immuno-oncology Diagnosis Major Product Offerings
  7.28.4 Clinical Genomics Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.28.5 Clinical Genomics Key News
7.29 Pfizer
  7.29.1 Pfizer Corporate Summary
  7.29.2 Pfizer Business Overview
  7.29.3 Pfizer Immuno-oncology Diagnosis Major Product Offerings
  7.29.4 Pfizer Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.29.5 Pfizer Key News
7.30 Promega
  7.30.1 Promega Corporate Summary
  7.30.2 Promega Business Overview
  7.30.3 Promega Immuno-oncology Diagnosis Major Product Offerings
  7.30.4 Promega Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.30.5 Promega Key News
7.31 Protagen Diagnostics
  7.31.1 Protagen Diagnostics Corporate Summary
  7.31.2 Protagen Diagnostics Business Overview
  7.31.3 Protagen Diagnostics Immuno-oncology Diagnosis Major Product Offerings
  7.31.4 Protagen Diagnostics Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.31.5 Protagen Diagnostics Key News
7.32 Qiagen
  7.32.1 Qiagen Corporate Summary
  7.32.2 Qiagen Business Overview
  7.32.3 Qiagen Immuno-oncology Diagnosis Major Product Offerings
  7.32.4 Qiagen Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.32.5 Qiagen Key News
7.33 Quanterix
  7.33.1 Quanterix Corporate Summary
  7.33.2 Quanterix Business Overview
  7.33.3 Quanterix Immuno-oncology Diagnosis Major Product Offerings
  7.33.4 Quanterix Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.33.5 Quanterix Key News
7.34 Rarecells SAS
  7.34.1 Rarecells SAS Corporate Summary
  7.34.2 Rarecells SAS Business Overview
  7.34.3 Rarecells SAS Immuno-oncology Diagnosis Major Product Offerings
  7.34.4 Rarecells SAS Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.34.5 Rarecells SAS Key News
7.35 Roche Diagnostics
  7.35.1 Roche Diagnostics Corporate Summary
  7.35.2 Roche Diagnostics Business Overview
  7.35.3 Roche Diagnostics Immuno-oncology Diagnosis Major Product Offerings
  7.35.4 Roche Diagnostics Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.35.5 Roche Diagnostics Key News
7.36 Siemens
  7.36.1 Siemens Corporate Summary
  7.36.2 Siemens Business Overview
  7.36.3 Siemens Immuno-oncology Diagnosis Major Product Offerings
  7.36.4 Siemens Immuno-oncology Diagnosis Revenue in Global Market (2017-2022)
  7.36.5 Siemens Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Immuno-oncology Diagnosis Market Opportunities & Trends in Global Market
Table 2. Immuno-oncology Diagnosis Market Drivers in Global Market
Table 3. Immuno-oncology Diagnosis Market Restraints in Global Market
Table 4. Key Players of Immuno-oncology Diagnosis in Global Market
Table 5. Top Immuno-oncology Diagnosis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Immuno-oncology Diagnosis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Immuno-oncology Diagnosis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Immuno-oncology Diagnosis Product Type
Table 9. List of Global Tier 1 Immuno-oncology Diagnosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immuno-oncology Diagnosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Immuno-oncology Diagnosis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Immuno-oncology Diagnosis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Immuno-oncology Diagnosis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Immuno-oncology Diagnosis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Immuno-oncology Diagnosis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Immuno-oncology Diagnosis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Immuno-oncology Diagnosis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Immuno-oncology Diagnosis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Immuno-oncology Diagnosis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Immuno-oncology Diagnosis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Immuno-oncology Diagnosis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Immuno-oncology Diagnosis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Immuno-oncology Diagnosis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Immuno-oncology Diagnosis Revenue, (US$, Mn), 2023-2028
Table 30. 10x Genomics Corporate Summary
Table 31. 10x Genomics Immuno-oncology Diagnosis Product Offerings
Table 32. 10x Genomics Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Laboratories Corporate Summary
Table 34. Abbott Laboratories Immuno-oncology Diagnosis Product Offerings
Table 35. Abbott Laboratories Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 36. Abcam Corporate Summary
Table 37. Abcam Immuno-oncology Diagnosis Product Offerings
Table 38. Abcam Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 39. Adaptive Biotechnologies Corporate Summary
Table 40. Adaptive Biotechnologies Immuno-oncology Diagnosis Product Offerings
Table 41. Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 42. Aethlon Medical Corporate Summary
Table 43. Aethlon Medical Immuno-oncology Diagnosis Product Offerings
Table 44. Aethlon Medical Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 45. Agena Bioscience Corporate Summary
Table 46. Agena Bioscience Immuno-oncology Diagnosis Product Offerings
Table 47. Agena Bioscience Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 48. Angle plc Corporate Summary
Table 49. Angle plc Immuno-oncology Diagnosis Product Offerings
Table 50. Angle plc Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 51. Apocell Corporate Summary
Table 52. Apocell Immuno-oncology Diagnosis Product Offerings
Table 53. Apocell Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 54. ARUP Laboratories Corporate Summary
Table 55. ARUP Laboratories Immuno-oncology Diagnosis Product Offerings
Table 56. ARUP Laboratories Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 57. Beckman Coulter Corporate Summary
Table 58. Beckman Coulter Immuno-oncology Diagnosis Product Offerings
Table 59. Beckman Coulter Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 60. Becton Dickinson Corporate Summary
Table 61. Becton Dickinson Immuno-oncology Diagnosis Product Offerings
Table 62. Becton Dickinson Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 63. Bioarray Genetics Corporate Summary
Table 64. Bioarray Genetics Immuno-oncology Diagnosis Product Offerings
Table 65. Bioarray Genetics Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 66. BioCartis Corporate Summary
Table 67. BioCartis Immuno-oncology Diagnosis Product Offerings
Table 68. BioCartis Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 69. Biocept Corporate Summary
Table 70. Biocept Immuno-oncology Diagnosis Product Offerings
Table 71. Biocept Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 72. Biodesix Inc Corporate Summary
Table 73. Biodesix Inc Immuno-oncology Diagnosis Product Offerings
Table 74. Biodesix Inc Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 75. BioFluidica Corporate Summary
Table 76. BioFluidica Immuno-oncology Diagnosis Product Offerings
Table 77. BioFluidica Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 78. BioGenex 40 bioM?rieux Corporate Summary
Table 79. BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Product Offerings
Table 80. BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 81. Bio-Rad Corporate Summary
Table 82. Bio-Rad Immuno-oncology Diagnosis Product Offerings
Table 83. Bio-Rad Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 84. Bio-Techne Corporate Summary
Table 85. Bio-Techne Immuno-oncology Diagnosis Product Offerings
Table 86. Bio-Techne Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 87. Bristol-Myers Squibb Corporate Summary
Table 88. Bristol-Myers Squibb Immuno-oncology Diagnosis Product Offerings
Table 89. Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 90. Cancer Genetics Corporate Summary
Table 91. Cancer Genetics Immuno-oncology Diagnosis Product Offerings
Table 92. Cancer Genetics Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 93. Caris Molecular Diagnostics Corporate Summary
Table 94. Caris Molecular Diagnostics Immuno-oncology Diagnosis Product Offerings
Table 95. Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 96. CellMax Life Corporate Summary
Table 97. CellMax Life Immuno-oncology Diagnosis Product Offerings
Table 98. CellMax Life Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 99. Charles River Laboratories Corporate Summary
Table 100. Charles River Laboratories Immuno-oncology Diagnosis Product Offerings
Table 101. Charles River Laboratories Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 102. Chronix Biomedical Corporate Summary
Table 103. Chronix Biomedical Immuno-oncology Diagnosis Product Offerings
Table 104. Chronix Biomedical Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 105. Circulogene Corporate Summary
Table 106. Circulogene Immuno-oncology Diagnosis Product Offerings
Table 107. Circulogene Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 108. Clearbridge BioMedics Corporate Summary
Table 109. Clearbridge BioMedics Immuno-oncology Diagnosis Product Offerings
Table 110. Clearbridge BioMedics Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 111. Clinical Genomics Corporate Summary
Table 112. Clinical Genomics Immuno-oncology Diagnosis Product Offerings
Table 113. Clinical Genomics Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 114. Pfizer Corporate Summary
Table 115. Pfizer Immuno-oncology Diagnosis Product Offerings
Table 116. Pfizer Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 117. Promega Corporate Summary
Table 118. Promega Immuno-oncology Diagnosis Product Offerings
Table 119. Promega Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 120. Protagen Diagnostics Corporate Summary
Table 121. Protagen Diagnostics Immuno-oncology Diagnosis Product Offerings
Table 122. Protagen Diagnostics Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 123. Qiagen Corporate Summary
Table 124. Qiagen Immuno-oncology Diagnosis Product Offerings
Table 125. Qiagen Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 126. Quanterix Corporate Summary
Table 127. Quanterix Immuno-oncology Diagnosis Product Offerings
Table 128. Quanterix Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 129. Rarecells SAS Corporate Summary
Table 130. Rarecells SAS Immuno-oncology Diagnosis Product Offerings
Table 131. Rarecells SAS Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 132. Roche Diagnostics Corporate Summary
Table 133. Roche Diagnostics Immuno-oncology Diagnosis Product Offerings
Table 134. Roche Diagnostics Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)
Table 135. Siemens Corporate Summary
Table 136. Siemens Immuno-oncology Diagnosis Product Offerings
Table 137. Siemens Immuno-oncology Diagnosis Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Immuno-oncology Diagnosis Segment by Type in 2021
Figure 2. Immuno-oncology Diagnosis Segment by Application in 2021
Figure 3. Global Immuno-oncology Diagnosis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Immuno-oncology Diagnosis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Immuno-oncology Diagnosis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immuno-oncology Diagnosis Revenue in 2021
Figure 8. By Type - Global Immuno-oncology Diagnosis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Immuno-oncology Diagnosis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Immuno-oncology Diagnosis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Immuno-oncology Diagnosis Revenue Market Share, 2017-2028
Figure 12. US Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Immuno-oncology Diagnosis Revenue Market Share, 2017-2028
Figure 16. Germany Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 17. France Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Immuno-oncology Diagnosis Revenue Market Share, 2017-2028
Figure 24. China Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 28. India Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Immuno-oncology Diagnosis Revenue Market Share, 2017-2028
Figure 30. Brazil Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Immuno-oncology Diagnosis Revenue Market Share, 2017-2028
Figure 33. Turkey Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Immuno-oncology Diagnosis Revenue, (US$, Mn), 2017-2028
Figure 37. 10x Genomics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Laboratories Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Abcam Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Aethlon Medical Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Agena Bioscience Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Angle plc Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Apocell Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. ARUP Laboratories Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Beckman Coulter Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Becton Dickinson Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Bioarray Genetics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. BioCartis Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Biocept Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Biodesix Inc Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. BioFluidica Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Bio-Rad Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Bio-Techne Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Cancer Genetics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. CellMax Life Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Charles River Laboratories Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Chronix Biomedical Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. Circulogene Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 63. Clearbridge BioMedics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 64. Clinical Genomics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 65. Pfizer Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 66. Promega Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 67. Protagen Diagnostics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 68. Qiagen Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 69. Quanterix Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 70. Rarecells SAS Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 71. Roche Diagnostics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 72. Siemens Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)